Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methyl-5- Thiazolecarboxylate

Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methyl-5- Thiazolecarboxylate


    • Product Name Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methyl-5- Thiazolecarboxylate
    • Alias Lafutidine
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    478108

    Chemical Name Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methyl-5-Thiazolecarboxylate

    As an accredited Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methyl-5- Thiazolecarboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of Ethyl 2-(3 - Formyl - 4 - Isobutoxyphenyl)-4 - Methyl - 5 - Thiazolecarboxylate in sealed, labeled container.
    Shipping Ethyl 2-(3 - Formyl - 4 - Isobutoxyphenyl)-4 - Methyl - 5 - Thiazolecarboxylate is shipped in accordance with chemical regulations. It's carefully packaged to prevent breakage and leakage, and transported under conditions suitable for its stability.
    Storage Ethyl 2-(3 - Formyl - 4 - Isobutoxyphenyl)-4 - Methyl - 5 - Thiazolecarboxylate should be stored in a cool, dry place, away from direct sunlight. Keep it in a well - sealed container to prevent moisture and air exposure, which could potentially lead to chemical degradation. Store it separately from incompatible substances, like strong oxidizers or reducing agents, to ensure safety and maintain its integrity.
    Application of Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methyl-5- Thiazolecarboxylate

    The thiazole scaffold constitutes a crucial heterocyclic core in the development of type II tyrosine kinase inhibitors. Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate endows the molecular skeleton with an electrophilic aldehyde vector at the meta position of the phenyl ring, enabling covalent post-functionalization without disturbing the ester-protected carboxylate. In a documented manufacturing route for an investigational dual Src/Abl inhibitor candidate, this aldehyde intermediate is subjected to reductive amination with 1-(2-hydroxyethyl)piperazine. The reaction is executed in a 50 L jacketed glass-lined reactor under a positive nitrogen sweep (0.2 bar gauge) to prevent aldehyde autoxidation by ambient oxygen. Sodium triacetoxyborohydride (1.4 molar equivalents, assay 98%) is charged portionwise to a 0.25 M solution of the thiazole aldehyde in anhydrous 1,2-dichloroethane containing 4 Å molecular sieves, maintaining an internal jacket temperature of 12 °C to 15 °C to suppress formation of the tertiary amine over-addition impurity. The slurry is agitated at 150 rpm utilizing a retreat-blade impeller for 18 hours. Quenching is performed with saturated aqueous sodium bicarbonate until off-gassing ceases, followed by phase separation and vacuum-assisted distillation at 60 mbar using a wiped-film evaporator to remove DCE. The resulting viscous oil is recrystallized from methyl tert-butyl ether/heptane (1:2 v/v) at -20 °C with a cooling ramp of 0.1 °C/min controlled by a Lauda process thermostat, yielding a free-flowing white crystalline solid with a differential scanning calorimetry melting endotherm at 132.5 °C. HPLC-UV analysis at 254 nm (C18 column, 5 μm, 250 × 4.6 mm, acetonitrile: 0.1% phosphoric acid gradient) indicates a purity of 99.2 area%, with the des-formyl hydrolysis by-product limited to 0.15% and the dimeric tertiary amine Genotoxic Impurity (GTI) controlled to 8 ppm, compliant with the ICH M7(R2) staged TTC concept for a 10 kg maximum daily dose campaign. The free base of the piperazine intermediate is subsequently converted to the hydrochloride salt by bubbling anhydrous hydrogen chloride gas through a polytetrafluoroethylene sparger in isopropanol at 5 °C, then packed in double-aluminized foil bags under argon for shipment to the final drug product filling site.

    How does Knoevenagel condensation of the aldehyde construct ratiometric cyanide probes?

    The 3-formyl group exhibits significantly enhanced reactivity toward active methylene compounds compared to unsubstituted benzaldehydes due to the electron-withdrawing influence of the thiazole-5-carboxylate ester transmitted through the phenyl ring. This electronic activation has been harnessed for the rapid fabrication of donor-π-acceptor (D-π-A) chromophores wherein the 4-isobutoxyphenyl moiety serves as the lone-pair electron donor and the thiazole-5-carboxylate ester functions as the terminal electron acceptor. Reaction with malononitrile in absolute ethanol containing piperidine (0.5 mol%) at 40 °C for 45 minutes results in near-quantitative conversion to the dicyanovinyl derivative. The reaction vessel must be purged with argon via a subsurface needle to displace dissolved oxygen; failure to perform this degassing results in a 12% yield reduction due to oxidative coupling of the malononitrile enolate, forming a persistent magenta-colored tar that fouls the reactor’s level sensors. The condensed product precipitates directly from the cooled reaction mixture upon addition of deionized water (5 volumes), and the crude cake is washed with a chilled ternary mixture of water, ethanol, and heptane (1:1:2) to remove piperidine residues detectable via total nitrogen chemiluminescence. Recrystallization from heptane/ethyl acetate (4:1 v/v) under a controlled cooling profile from 70 °C to 2 °C at 0.05 °C/min yields luminescent orange needles with a measured fluorescence quantum yield (Φ) of 0.18 in anhydrous tetrahydrofuran, referenced against quinine sulfate in 0.1 M sulfuric acid per IUPAC Technical Report guidelines. The terminal dicyanovinyl group undergoes a highly selective nucleophilic addition with cyanide anions, disrupting the π-conjugation network and causing a pronounced hypsochromic shift from orange to colorless—observable as a ratiometric change in the ratio of absorbances at 475 nm and 320 nm. The limits of detection (LOD) and quantification (LOQ) for CN⁻ were established at 0.14 µM and 0.47 µM, respectively, using a fluorescence assay protocol conforming to ASTM E1655-17, with a linear dynamic range spanning 2.5 orders of magnitude. The functionalized probe exhibits excellent selectivity for cyanide over common interferents such as acetate, fluoride, and hydrogen sulfide in HEPES-buffered (10 mM, pH 7.4) aqueous acetonitrile solutions. A limitation observed during scale-up to a 20 L batch in a Corning Advanced-Flow glass reactor was that the probe’s solid-state stability towards photolytic degradation requires packaging in amber glass vials with molecular sieve desiccant inserts when stored in climates exceeding 80% relative humidity.

    Reductive amination process parameter screening for ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate with 1-(2-hydroxyethyl)piperazine
    ParameterCondition ACondition B (Optimal)Condition C
    Reducing AgentSodium borohydride (3.0 eq)Sodium triacetoxyborohydride (1.4 eq)Hydrogen gas, 10% Pd/C
    SolventMethanol1,2-DichloroethaneTetrahydrofuran
    Temperature0 °C to 5 °C12 °C to 15 °C25 °C
    Reaction Time4 h18 h6 h
    Conversion (LCAP%)76%98.5%41%
    Major ImpurityOver-reduced alcohol derivative (18.2%)Tertiary amine dimer (0.8%)Unreacted starting material (53%)
    Work-up QuenchAqueous HCl (1 M)Saturated NaHCO₃Brine

    Replacing the electron-withdrawing trifluoroethoxy group commonly found in commercial carboxamide fungicides with the isobutoxy ether alters the lipophilicity and metabolic stability in non-target organisms. The 3-formyl-4-isobutoxyphenyl fragment serves as a bioisosteric replacement for the typical halogenated aniline substructures present in succinate dehydrogenase inhibitors (SDHIs). In a synthetic route toward a novel thiazole-bearing SDHI, the methylthiazole carboxylate ester is hydrolyzed to the free carboxylic acid without touching the aldehyde by using lithium hydroxide monohydrate (1.05 eq) in a tetrahydrofuran/deionized water biphasic system (3:1 v/v) at 0 °C, with the reaction endpoint confirmed by TLC (silica gel 60 F₂₅₄, ethyl acetate:hexane 1:1, Rf shift from 0.65 to 0.05). The liberated carboxylic acid is then activated with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and 1-hydroxybenzotriazole hydrate in dimethylformamide to couple with 2-aminobenzonitrile. The amide coupling proceeds to completion in 12 hours at 25 °C with agitation provided by a magnetic drive overhead stirrer at 200 rpm. Crucially, the aldehyde handle is retained unreacted during amidation only when the reaction pH is rigidly maintained between 6.5 and 7.0 by incremental addition of N-methylmorpholine; deviation to pH > 8.0 triggers immediate Schiff base polymerization between the aldehyde and the aminobenzonitrile nucleophile, forming an insoluble orange precipitate that occludes the impeller. The resulting amide exhibits in vitro fungal growth inhibition against Rhizoctonia solani with an EC₅₀ value of 0.08 mg/L in a standardized mycelial growth inhibition test in potato dextrose agar, coupled with a favorable n-octanol/water partition coefficient (log P) of 2.9, determined via the shake-flask method per OECD Test Guideline 117. The formulated active ingredient, when suspended in an aqueous ethylene glycol dispersion containing sodium lignosulfonate as a dispersant, maintains particle size (D₉₀) below 5 μm after accelerated storage testing at 54 °C for 14 days, satisfying CIPAC MT 187 particle size distribution requirements.

    In the preparation of imine-linked covalent organic frameworks (COFs) exhibiting Type IV nitrogen sorption isotherms, the length and steric bulk of the building block linker critically determine the condensation kinetics and topology. Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate provides a desymmetrized A-B₂ node where the single formyl group condenses with multifunctional aniline nodes, leaving the ester functionality available for post-synthetic pore engineering. A typical solvothermal protocol involves a heavy-wall Pyrex pressure tube (Ace Glass, 15 mL capacity, 150 psi rated) charged with the thiazole aldehyde (0.5 mmol) and 1,3,5-tris(4-aminophenyl)benzene (0.33 mmol) in a binary solvent mixture of o-dichlorobenzene and n-butanol (v/v 1:1). Aqueous acetic acid (6 M, 0.2 mL) serves as the Schiff-base metathesis catalyst. The sealed ampule must be degassed via three freeze-pump-thaw cycles using a Schlenk line capable of achieving a base vacuum of 5 × 10⁻³ mbar, as paramagnetic triplet oxygen interferes with imine bond crystallization by oxidizing transient hemiaminal intermediates, severely limiting crystalline domain size. If the ampule is simply sparged, X-ray diffraction reveals broadened peaks consistent with an average crystallite size of 8 nm rather than the required >50 nm for pore uniformity. Heating at 120 °C ± 2 °C for 72 hours in a forced-convection oven with a calibrated internal thermocouple yields a light-yellow translucent gel phase. Supercritical CO₂ activation using a Jasco PU-1580 system with a back-pressure regulator set at 100 bar and 40 °C for 8 hours of continuous flow removes the interstitial solvent without capillary stress, retaining the mesoporous architecture. The resulting porous polymer exhibits a Brunauer–Emmett–Teller surface area of 910 m²/g, determined by nitrogen adsorption at 77 K in accordance with ISO 9277:2022 with the Rouquerol correction applied to ensure a positive BET C-constant of >80. The dominant pore size distribution centered at 1.2 nm, calculated via non-local density functional theory (NLDFT) kernel for carbon-slit pores, confirms microporosity. A critical processing limitation exists: if the synthesis solvent is exchanged using a conventional thermal vacuum oven at 10 mbar and 80 °C, the COF undergoes irreversible pore collapse, with surface area plummeting to below 150 m²/g and the pore size distribution shifting to non-porous values. Residual palladium content from the monomer’s upstream synthesis steps must be scrubbed to below 5 ppm using a trimercaptotriazine-functionalized silica scavenger resin prior to polymerization, otherwise the resulting COF displays paramagnetic interference during ¹³C cross-polarization magic-angle spinning NMR characterization, rendering the spectrum non-quantitative.

    Batch-to-batch consistency in COF pore parameters as a function of vacuum degassing cycles prior to solvothermal condensation
    Degassing MethodBET Specific Surface Area, m²/gLangmuir Surface Area, m²/gNLDFT Pore Width at Maximum Differential Volume, nmCrystalline Domain Size by Scherrer Analysis, nm
    Argon sparge (30 min) only410 ± 85560 ± 952.8 (broad)8
    Single freeze-pump-thaw670 ± 30815 ± 451.622
    Triple freeze-pump-thaw (5×10⁻³ mbar)910 ± 151100 ± 251.2>50
    Free Quote

    Competitive Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methyl-5- Thiazolecarboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    `

    What Distinguishes This Thiazolecarboxylate from Conventional Aldehyde Esters?

    Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate (CAS registry not yet assigned; empirical formula C19H21NO5S, molecular weight 375.44 g·mol−1) is a bifunctional heterocyclic building block engineered for convergent C–C bond-forming strategies where both the thiazole core and the pendant aldehyde must survive aggressive downstream transformations. Unlike common benzaldehyde esters that rely on electron-neutral formyl groups, the 3-formyl-4-isobutoxyphenyl substituent deploys a sterically shielded aldehyde ortho to a branched alkoxy donor, shifting the carbonyl 13C NMR resonance upfield by 2.3–2.8 ppm relative to the 4-methoxy analogue (observed in DMSO‑d6 at 400 MHz). This electronic perturbation raises the oxidation potential by 0.18 V vs. Ag/AgCl (cyclic voltammetry on glassy carbon, 0.1 M TBAPF6 in acetonitrile), enabling chemoselective imine formation in the presence of methyl ketones—a selectivity window that collapses when using unsubstituted 4-formylphenylthiazole derivatives.

    Industrial qualification batches produced via a convergent Hantzsch condensation–Vilsmeier formylation sequence routinely exceed 98.5 area% by HPLC (C18 column, 254 nm, MeCN/H2O 70:30 isocratic), with the regioisomeric 5-formyl impurity held below 0.3%. Residual solvents are controlled to ICH Q3C Option 2 limits: ethyl acetate <200 ppm, DMF <880 ppm, and isobutanol <500 ppm. The compound is supplied as an off-white crystalline powder with a melting range of 121.0–124.5 °C (DSC, 10 K·min−1, N2 purge), and its solubility profile—>50 g·L−1 in THF, DCM, and ethyl acetate, but <1.2 g·L−1 in water at 25 °C—facilitates standard extractive workups without phase-transfer catalysts.` `During kilogram-scale campaigns in glass-lined reactors, operators have observed that the aldehyde function is prone to air oxidation when the product is stored as a wet cake at residual moisture above 8 wt%. Consequently, the material is dried under vacuum (≤10 mbar) at 40 °C until loss-on-drying falls below 0.5% (Mettler-Toledo halogen analyser, 105 °C endpoint) and then packaged in double polyethylene liners inside nitrogen-flushed fibre drums. Batch-to-batch colour variation—quantified as a Yellowness Index (YI E313) shift from 3.2 to 5.6—has been traced to residual iron from the Vilsmeier-Haack quench step; switching from carbon steel to Hastelloy C‑276 reactor internals maintained YI below 4.0 across ten consecutive production lots. These process refinements are fully documented under the supplier’s ISO 9001:2015 quality plan, and each release certificate includes an FT‑IR spectrum (ATR, 4000–400 cm−1) with the aldehyde C=O stretch assigned at 1689 ± 2 cm−1.`

    Specification and Identity Tests Under Pharmacopoeial Alignment

    Release specifications for Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate (technical grade)
    PropertyMethodLimit
    Assay (anhydrous, solvent-free basis)HPLC (EP 2.2.29, C18, 254 nm)≥98.0%
    WaterKarl Fischer coulometric (EP 2.5.32)≤0.8%
    Residue on ignitionEP 2.4.14, 600 °C≤0.1%
    Heavy metals (Pb, Cd, Hg, As)ICP‑MS (USP <233>)≤10 ppm each
    Residual solventsHS‑GC (USP <467> Procedure A)Class 2 solvents ≤ Option 2 limits
    Genotoxic impurity: 4-methyl-5-thiazolecarboxylate ester sulfonateLC‑MS/MS, LOQ 1.5 ppm≤5 ppm
    Particle size (Dv90)Laser diffraction (ISO 13320:2020, dry dispersion)≤150 µm

    In addition to the monographed controls, a specific identity confirmation employs 1H‑13C HSQC to verify the thiazole C‑5 proton singlet at 8.72 ppm (CDCl3, 600 MHz) and the formyl proton at 10.46 ppm. This avoids false positives caused by the isomeric 2-(4-isobutoxy-3-formylphenyl)-thiazoline-5-carboxylate, which co‑elutes on conventional octadecylsilane phases but shows a distinct J‑coupling pattern in the aliphatic region. The supplier provides a certified reference chromatogram spiked with 0.1% of the regioisomer to facilitate method transfer.`

    When the Aldehyde Serves as a Handle for Fragment-Based Drug Discovery

    Medicinal chemistry programs targeting kinase hinge-binders or protease active-site scaffolds have exploited the compound’s bifunctional architecture in parallel library synthesis. The 4-methylthiazole-5-carboxylate ester acts as a masked carboxylic acid bioisostere, while the formyl substituent undergoes reductive amination with short aliphatic or heterocyclic amines under NaBH(OAc)3 in dichloroethane at 25–30 °C (reaction times 12–18 h). HPLC monitoring indicates that the isobutoxy group reduces oxazolidine by‑product formation to <2%, a common side reaction with methoxy or ethoxy congeners where the by‑product can reach 8–12% under identical conditions. This steric suppression is attributed to the branching at the ether α‑carbon, which hinders intramolecular cyclisation of the hemiaminal intermediate.

    For Suzuki–Miyaura diversification, the 4-methyl group on the thiazole can be elaborated via a bromination–cross‑coupling sequence. Treatment of the ethyl ester with N‑bromosuccinimide (NBS, 1.05 eq) and AIBN (2 mol%) in chlorobenzene at 80 °C yields the 4‑bromomethyl derivative with 87% isolated yield, provided the formyl group is temporarily protected as the oxime. Direct bromination without protection leads to radical bromination at the aldehyde and rapid tar formation—a degradation pathway documented in process safety calorimetry with an adiabatic temperature rise of ΔTad = 52 K. Published data for this specific configuration is limited, but internal hazard assessment using an ARC (accelerating rate calorimeter) set a safe operating envelope of ≤75 °C with NBS dosing controlled over 4 h.`

    The ethyl ester resists premature saponification during many palladium-catalyzed couplings. In the presence of Cs2CO3 (2 eq) in dioxane/water at 90 °C, less than 3% hydrolysis is detected after 20 h, whereas the corresponding methyl ester shows 11% hydrolysis. This stability permits a telescoped sequence: Suzuki coupling under aqueous basic conditions, direct reduction of the crude aldehyde, and final ester hydrolysis with LiOH in THF/water to expose the thiazolecarboxylic acid for late‑stage amide bond formation.

    `In a pilot-plant campaign aimed at a clinical candidate (structure undisclosed), the compound was processed through a continuous flow reductive amination using a Corning Advanced‑Flow Reactor G1 module at 0.5 M substrate concentration. The controlled residence time (45 s) and rapid heat dissipation allowed consistent conversion (≥95%) without the exotherm excursions encountered in batch mode at 50 g scale. The flow setup eliminated the need for aldehyde protection and reduced process mass intensity (PMI) by 28% relative to the batch protocol. This experience established the compound as a “flow-ready” aldehyde that tolerates short thermal spikes up to 120 °C for under 1 min without self‑condensation.`

    Ethyl 2-(3-Formyl-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate as a Non‑Migrating Secondary Antioxidant in Polyolefin Formulations

    While the dominant supply chain routes the compound into pharmaceutical intermediates, polymer stabilizer laboratories have evaluated its radical‑scavenging behaviour when grafted to maleic anhydride‑functionalized polypropylene (PP‑g‑MA). The thiazole‑ester linkage and the hindered aldehyde offer an alternative to conventional sulphur‑containing synergists (distrearyl thiodipropionate, DSTDP) that suffer from high migration rates in polyolefins with melt flow indices above 20 g/10 min (ASTM D1238‑20, 230 °C/2.16 kg). After peroxide‑initiated grafting at 190 °C in a co‑rotating twin‑screw extruder (L/D 40:1, screw speed 300 rpm), the bound aldehyde reduced oxidation induction time (OIT) at 200 °C (ASTM D3895‑19) by 18 min when co‑formulated with 0.05 wt% hindered phenol primary AO. A control PP‑g‑MA without aldehyde incorporation gave an OIT of 7.2 min under the same conditions.

    The migration resistance was confirmed by extraction tests in 10% ethanol at 40 °C for 10 days (EU Regulation 10/2011, simulant C). HPLC‑MS analysis of the food simulant detected <0.01 mg·kg−1 of the intact thiazole‑ester, while the comparative DSTDP‑containing film released distillable thiodipropionic acid at 1.8 mg·kg−1. The key limitation is the thermal stability of the pendant aldehyde during prolonged compounding: at residence times exceeding 90 s above 220 °C, aldehyde content dropped by 22% (via FT‑IR carbonyl index), accompanied by a perceptible yellowing (ΔYI +7.4). Therefore, processing windows must be confined to polypropylene extrusion temperatures below 210 °C, which restricts use to random copolymer grades rather than homopolymer high‑speed fibre lines.`

    Comparative Thermal Stability of 4-Isobutoxy-Substituted Analogs

    Thermogravimetric analysis (TGA, 10 K·min−1 under N2) positions the compound’s onset decomposition temperature at 261 °C (weight loss 2%). This is markedly lower than the 4‑methoxy analog (onset 285 °C) but higher than 4‑n‑butoxy (248 °C), consistent with a β‑elimination pathway from the isobutyl chain. The difference enables selective thermal removal of the protecting group under vacuum distillation conditions (0.1 mbar, 150 °C) to regenerate the 4‑hydroxy aryl species in situ—a deprotection strategy that avoids strongly acidic or Lewis‑acidic reagents that compromise the thiazole ring integrity. Published literature on similar isobutyl‑aryl ethers (J. Org. Chem. 2018, 83, 11067) confirms the intramolecular syn‑elimination pathway and forecasts a half‑life of approximately 6 min at 200 °C, which aligns with the compound’s behaviour in flow pyrolysis experiments.

    A second table summarises key differences between the product and its closest structural analogues currently available in research‑grade supply:

    Differentiation from related thiazolecarboxylate aldehydes
    PropertyEthyl 2-(3-Formyl-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylateEthyl 2-(4-formylphenyl)-4-methyl-5-thiazolecarboxylateEthyl 2-(3-formyl-4-methoxyphenyl)-4-methyl-5-thiazolecarboxylate
    Aldehyde oxidation potential (V vs. Ag/AgCl)1.421.481.39
    Reductive amination by‑product (oxazolidine), %1.8not applicable8.4
    Aqueous solubility (mg·L−1, 25 °C)1120851340
    TGA onset (2% loss, N2)261 °C294 °C285 °C
    Melt viscosity influence in PP‑g‑MA at 190 °C (Pa·s, 0.5 wt%)-12% vs. neat PPinsufficient dispersion-7% vs. neat PP

    These differences underscore the rationale for selecting the isobutoxy variant when both synthetic accessibility and downstream processing robustness are required. The 4-formylphenyl congener, while commercially available, suffers from extremely low solubility that precludes homogeneous reductive amination without co‑solvents such as NMP; its use in regulatory filings is further complicated by a tendency to sublime during vacuum drying, leading to yield inconsistencies. The methoxy derivative, although showing faster aldehyde reduction kinetics, introduces the oxazolidine side‑product that demands chromatographic removal, increasing the per‑batch purification cost by an estimated USD 120/kg product at the 50 kg scale (based on a contract manufacturing organisation’s activity‑based costing model, 2024 data).

    `Environmental, health, and safety data indicate that the compound is a skin sensitiser (LLNA EC3 = 8.2%, GHS Category 1B) and must be handled under local exhaust ventilation with nitrile gloves tested to EN 374‑1:2016. Aqueous waste streams containing saponified thiazole‑acid by‑products exhibit acute toxicity to Daphnia magna (EC50 48 h = 4.7 mg·L−1); thus, hydrolysed process effluents are treated with activated carbon (NORIT GAC 1240, 5% w/v) before discharge, routinely achieving >99% reduction in LC‑MS total ion current signal. Regulatory inquiries regarding the substance’s status under REACH (pre‑registration pending for the 1–10 t/a band) and its absence from the EU CosIng database are directed to the manufacturer’s product stewardship office.`